Confocal images of the SVZ and the DG. by Katarzyna Bartkowska (453261)

Subjects:

Representative immunofluorescence images for S100A6 in brainstem structures in control and stressed mice. by Katarzyna Bartkowska (453261)

Subjects:

Results of western blots showing the protein levels in different brain structures. by Katarzyna Bartkowska (453261)

Subjects:

Confocal images presenting the phenotypes of S100A6-immunopositive cells in the SVZ. by Katarzyna Bartkowska (453261)

Subjects:

Confocal images of brain sections immunostained with S100A6 and vimentin antibodies. by Katarzyna Bartkowska (453261)

Subjects:

Representative immunofluorescence images for S100A6 in some brain structures related to stress responses. by Katarzyna Bartkowska (453261)

Subjects:

JC-1 monomer increased with the stimulation of sFlt-1 and decreased after administration of Z-LEHD-FMK in HUVECs. by Yaling Zhai (9239458)

Activation of macrophages decreases phagosomal copper availability and impairs proliferation of Ctr3-deficient yeasts. by Qian Shen (89639)

Decreased production of IL-12p70 and IL-23 in response to LPS+R848 stimulation in frail old individuals. by Nathalie Compté (418458)

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

SrpR binds the centromere-like region <i>srpC</i>. by Nicolas Carraro (650366)

Delphinidin alters VEGF-A splicing to increase VEGF-A₁₆₅b and decrease total VEGF-A expression. by Megan Stevens (3964886)

“…<p><b>A)</b> Treatment of podocytes with delphinidin chloride (10 μg/ml) under normal glucose (NG; 5 mM glucose + 25 mM mannitol) and high glucose (HG; 30 mM glucose, 1 ng/ml TNFα, 1 ng/ml IL-6, and 100 nM insulin) for 48 hrs increased the protein expression of VEGF-A₁₆₅b relative to total VEGF-A₁₆₅ (quantified in <b>B</b>; *p<0.05 vs NG, †p<0.05 vs HG; n = 3 biological repeats; One-way ANOVA with Bonferroni post-hoc test for comparison between pairs; <b>A</b>—the same blot was first probed with VEGF-A₁₆₅b before stripping and reprobing with panVEGF-A). …”

Antibacterial activity of medium derived from non-stimulated hADSCs (S) and stimulated by interferon gamma (ICM) on the growth of <i>P. aeruginosa, P. mirabilis</i> and <i>MRSA.</i... by Parisa Afzal Haghjoo (22453647)

Subjects:

Image3_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

Image2_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.JPEG by Sandra Torres (3361256)

Image4_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

Image1_The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis.TIF by Sandra Torres (3361256)

Levels of netrin-1, DCC, arginase, NO and ROS in endothelial cells. by Haroldo A. Toque (447341)

Subjects:

Molecular signaling in response to high glucose in endothelial cells. by Haroldo A. Toque (447341)

Subjects: